[1]
Moroz, H. 2025. The impact of iron metabolism disorders, transfusion load, and the use of erythropoiesis stimulants on quality of life, therapy tolerance and long-term survival of patients with chronic myeloid leukaemia after allogeneic stem cell transplantation cells. ScienceRise: Medical Science. 2(63) (Oct. 2025), 31–38. DOI:https://doi.org/10.15587/2519-4798.2025.340317.